Duchenne muscular dystrophy (DMD) is the second most commonly occurring genetically inherited disease in humans. It is an X-linked condition that affects approximately one in 3300 live male births. It is caused by the absence or disruption of the protein dystrophin, which is found in a variety of tissues, most notably skeletal muscle and neurones in particular regions of the CNS. Clinically DMD is characterized by a severe pathology of the skeletal musculature that results in the premature death of the individual. An important aspect of DMD that has received less attention is the role played by the absence or disruption of dystrophin on CNS function. In this review we concentrate on insights into this role gained from investigation of boys with DMD and the genetically most relevant animal model of DMD, the dystrophin-de®cient mdx mouse. Behavioural studies have shown that DMD boys have a cognitive impairment and a lower IQ (average 85), whilst the mdx mice display an impairment in passive avoidance re¯ex and in shortterm memory. In DMD boys, there is evidence of disordered CNS architecture, abnormalities in dendrites and loss of neurones, all associated with neurones that normally express dystrophin. In the mdx mouse, there have been reports of a 50% decrease in neurone number and neural shrinkage in regions of the cerebral cortex and brainstem. Histological evidence shows that the density of GABA A channel clusters is reduced in mdx Purkinje cells and hippocampal CA1 neurones. At the biochemical level, in DMD boys the bioenergetics of the CNS is abnormal and there is an increase in the levels of choline-containing compounds, indicative of CNS pathology. The mdx mice also display abnormal bioenergetics, with an increased level of inorganic phosphate and increased levels of choline-containing compounds. Functionally, DMD boys have EEG abnormalities and there is some preliminary evidence that synaptic function is affected adversely by the absence of dystrophin. Electrophysiological studies of mdx mice have shown that hippocampal neurones have an increased susceptibility to hypoxia. These recent ®ndings on the role of dystrophin in the CNS have implications for the clinical management of boys with DMD.
Introduction
Duchenne muscular dystrophy (DMD) is an X-linked recessive disease and has the second highest incidence of all inherited diseases, approximately one in 3300 live male births (Emery, 1991) . In boys the disease presents as muscle weakness that is ®rst apparent at 3±4 years of age. The muscle weakness is due to an irreversible, ongoing loss of skeletal muscle, and results in the need for a wheelchair at~10 years of age and death at~20 years, normally due to cardiorespiratory complications. The disease is a consequence of a mutation of the dystrophin gene, which comprises nearly 0.1% of the entire human genome (Koenig et al., 1987) . The dystrophin gene has a high mutation rate, with approximately one-third of all new cases of DMD resulting from a spontaneous mutation (Barbujani et al., 1990) . The product of the dystrophin gene was identi®ed in the ®rst successful application of the reverse genetics technique by both Kunkle (Kunkle et al., 1985) and Worton (Ray et al., 1985) . Since the identi®cation of the dystrophin protein and its location close to the inner surface of the plasmalemma there has been a substantial research effort aimed at investigating its physio-logical role in the cell membrane. These studies have mainly focused on skeletal muscle pathophysiology present in DMD and in animal models where dystrophin is known to be absent or present in a non-functional form. This work has given rise to two major hypotheses of the functional role of dystrophin in skeletal muscle The ®rst is a calcium hypothesis, where calcium homeostasis of the cell is disrupted (Wrogemann and Pena, 1976; Duncan, 1989; Head, 1993) resulting in an increase in intracellular calcium and cell necrosis. The second hypothesis suggests that dystrophin plays a structural role in maintaining the integrity of the lipid bilayer when it undergoes mechanical and osmotic stresses, and that in its absence the membrane ruptures allowing an in¯ux of extracellular ions, in particular calcium (Roses et al., 1975; Roses and Appel, 1976; Head et al., 1992) .
Many case reports of DMD have indicated a signi®cant CNS involvement, along with the skeletal muscle pathology that is characteristic of DMD. Indeed, Duchenne in his initial description noted that some boys displayed cognitive impairment (Duchenne, 1868) . It is now well established that dystrophin is present in many cells throughout the body, including neurones of the CNS. In this review we will present recent evidence demonstrating that the absence or mutation of dystrophin in the CNS results in a signi®cant disruption of neuronal and brain function. We will focus on work carried out in humans and in a dystrophin de®cient murine model of DMD, the mdx mouse.
Evidence linking the absence of dystrophin with a cognitive impairment In DMD boys
Since the original description of the disease by Duchenne (1868) in which he reported ®ve patients with some degree of cognitive impairment, there has been debate as to whether there is in fact a cognitive de®cit in the boys. This debate has been fuelled largely by con¯icting reports about the prevalence of cognitive impairment in individual cases of boys with DMD. Gowers noted that`in most recorded cases the mind has been unaffected' and concluded that intellectual impairment is not part of the disease (Gowers, 1879) . Similar ®ndings were reported by many investigators up until the 1970s (Morrow and Cohen, 1954; Walton and Natrass, 1954; Schoelly and Fraser, 1955; Truitt, 1955; Sherwin and McCully, 1961; Lincoln and Staples, 1977) . However, there is now an overwhelming amount of evidence supporting Duchenne's original observation that in many cases there is a signi®cant cognitive impairment. The average IQ of a boy with DMD is 85. The distribution of IQ in boys with DMD is shifted 1 SD lower, and consequently 30% of boys with DMD have an IQ of <70 (Allen and Rogkin, 1960; Worden and Vinos et al., 1962; Dubowitz, 1965 Dubowitz, , 1979 Zellweger and Niedermeyer, 1965; Zellweger and Hanson, 1967; Cohen et al., 1968; Prosser et al., 1969; Black, 1973; Marsh and Munsat, 1974; Florek and Karolak, 1977; Karagan and Zellweger, 1978; Karagan, 1979; Leibowitz and Dubowitz, 1981; Bresolin et al., 1994) .
Although some earlier reports found a decrease in IQ in DMD boys compared with age-matched controls (Scheinfeld, 1950; Black, 1973; Florek and Karolak, 1977) , the majority of studies, both longitudinal and correlational, found no such difference (Allen and Rodgin, 1960; Worden and Vignos, 1962; Zellweger and Niedermeyer, 1965; Zellweger and Hanson, 1967; Cohen et al., 1968; Prosser et al., 1969; Leibowitz and Dubowitz, 1981) . Others have reported an increase in verbal IQ and a decrease in performance IQ with age, with full IQ remaining static (Prosser et al., 1969; Karagan and Zellweger, 1976; Sollee et al., 1985) . Smith and colleagues reported that boys with DMD who were <6 years of age had a global developmental delay, particularly severe in language and locomotor areas, and showed a slight improvement with age (Smith et al., 1990) . De®cits in verbal expression and in memory (Karagan et al., 1980) , reading, mathematics and spelling (Dorman et al., 1988; Billard et al., 1998) and serial position memory (Anderson et al., 1988) have all been reported in DMD patients. Most recently Hinton and colleagues reported that regardless of IQ there was a speci®c cognitive pro®le, namely poor performance in digit span, story recall and comprehension, in a sample of 80 boys with DMD (Hinton et al., 2000) . The authors note that, although there was a consistent pro®le of cognitive impairment, it was variable in degree, possibly due to the different dystrophin gene mutations in the boys sampled.
The search for a genotype/phenotype correlation for cognitive impairment in DMD has not led to any conclusive results. It has been considered that deletions more towards the 3¢ end have a higher incidence of cognitive impairment (Bushby, 1992; Lenk et al., 1993) . Rapaport found that 70% of patients with a deletion in exon 52 had cognitive impairment (Rapaport et al., 1991) . Most recently, an association between the degree of cognitive impairment and the presence of mutation in the Dp71 isoform has been reported (Moizard et al., 2000) . (For a complete account of the full-length dystrophin and the various isoforms, see Blake and Kro Èger, 2000; Mehler, 2000.) In the mdx mouse
The mdx mouse is a murine model of DMD that lacks the full length dystrophin protein, but retains all the smaller dystrophin isoforms, including Dp71. Muntoni et al. (1991) were the ®rst to report a cognitive de®cit in the mdx mouse. Mice from 16±22 weeks old were found to have an impairment in passive avoidance learning. The cognitive impairment was further characterized by Vaillend and colleagues who found that mdx mice do not appear to have an impairment in task acquisition or in procedural memory, but rather they forget newly learned information more quickly than controls (Vaillend et al., 1995) . Of interest is the ®nding that the mdx mouse, and the mdx 3cv mouse (which lacks the full-length dystrophin as well as the smallest dystrophin isoform Dp71) are no different from controls in spatial discrimination tasks (Sesay et al., 1996; Vaillend et al., 1998) . Although the evidence is not as strong as in DMD, it appears that in mdx mice the mutation of the full-length dystrophin protein is also correlated with a degree of cognitive impairment.
Histological evidence for a CNS deformity In DMD boys
The results of brain autopsy, and more recently brain imaging, on DMD patients have not been consistent. Dubowitz and Crome investigated the brains on autopsy of 21 cases of classical DMD, and found only one case of abnormal brain weight and two cases where there werè striking histological abnormalities' (Dubowitz and Crome, 1969) . They concluded that DMD is not associated with any consistent gross or histological abnormality of the brain. Similarly, an MRI study by Bresolin and colleagues found no focal or generalized changes (Bresolin et al., 1994) , but the sample was very small (n = 4). Rae and colleagues in a study of 15 DMD boys and 15 age-matched controls found no signi®cant difference between these two groups in relative ventricular size, but stressed the young age (<13 years) of the boys in the sample (Rae et al., 1998b) .
In contrast, other investigators have reported brain abnormalities in DMD patients ranging from slight to severe (Rosman and Kakulas, 1966; Rosman, 1970; Jagadha and Becker, 1988; Itoh et al., 1999) . Among the abnormalities noted are neuronal loss, heterotopias, gliosis, neuro®brillary tangles, Purkinje cell loss, dendritic abnormalities (length, branching and intersections), disordered architecture, astrocytosis and perinuclear vacuolation. In 13 of 50 DMD patients studied, Bresolin and colleagues reported that the presence of macroglossia was signi®cantly correlated with a low performance IQ (Bresolin et al., 1994) . Schmidt et al. (1985) , in agreement with Appleton et al. (1991) , reported an increased head circumference in DMD patients, although these patients' fathers also showed greater head circumference as a group compared with normal. This was not the case in the mothers of these patients. They scanned (CT) three of the 36 subjects who were found to have a large head circumference and reported ®ndings of`probable megaencephaly'. The results of in situ brain measurements carried out on 30 DMD patients by Yoshioka et al. (1980) yielded more striking results. They found 67% of DMD patients studied had slight cortical atrophy, 60% had slight ventricular dilation and 30% had cortical atrophy, although clear signs of atrophy were only observed in older and more physically disabled patients (slight was de®ned as an enlargement of interhemispheric cisterns and sulci of 3±5 mm). Chen et al. (1999) reported a single DMD patient with mild brain atrophy, measured by CT scan.
There is some evidence to suggest that those DMD patients with identi®able brain abnormalities also show a cognitive impairment. Septien et al. (1991) studied 15 DMD patients, aged 4±16 years, in whom the average IQ was 84. In CT scans, 60% of the patients presented with slight cortical atrophy, with minimal dilation of the ventricles, interpreted as atrophy of the white matter. The nine cases presenting with cortical atrophy had an average IQ of 81, while the six presenting with normal CT scans had an average IQ of 90, although this difference was not statistically signi®cant. In agreement with Yoshioka et al. (1980) , they did ®nd that cortical atrophy was more common in patients older than 10 years. In contrast, al-Qudah et al . (1990) found no correlation between MRI ®ndings and verbal intelligence scores for four patients, two of whom were found to have mild atrophy consisting of dilation of lateral ventricles, CSF spaces and cerebral sulci. Overall these studies indicate that an abnormality of the brain, either gross or histological, is by no means common in DMD patients, and a correlation between abnormality and IQ impairment has yet to be clearly established. In those boys that do display abnormality in brain structure, the defects range from very mild to severe.
In the mdx mouse
In the original description of the mdx dystrophin de®cient mouse, Bul®eld et al. (1984) noted that the older (12 month old) mice displayed muscular tremors, possibly due to the older mdx mice having gross structural deformities in skeletal muscle, ranging from simple ®bre splitting to complex multiple branching (Head et al., 1992) . Interestingly, no gross abnormalities in brain or spinal cord were detected by Bul®eld et al. (1984) , or in a later study by Torres et al. (1987) . In contrast, Sbriccoli et al. (1995) employed retrograde axonal tracing to study the structure of the corticospinal system in mdx mice, and reported substantial differences between the brains of mdx mice and controls. They found that the absolute number of cells was decreased by 50% in mdx mice compared with controls. The cell packing density of cortical layer 5 neurones was higher in mdx than controls, while the cell packing density of corticospinal neurones was lower in mdx than controls. Corticospinal cells constituted 50% of neurones present in layer 5 of controls, but only 35% in mdx. The authors concluded that rather than a shrinkage of all layer 5 cell populations, the origin of the corticospinal tract was selectively damaged, and thus there were fewer labelled neurones in mdx than controls. It is important to note that they found the number of spinal motoneurones was no different between mdx and controls. The cross-sectional area of labelled neurones was~20% lower in mdx than controls, with the labelled cells also differing in shape (the mdx cells were rounder than the pyramidal-shaped control layer 5 cells). A more recent study by the same group (Carretta et al., 2001) investigated the organization of spinal projecting brainstem neurones. Cell counts of neurones were made in the red nucleus, the vestibular nuclear complex, the medullary reticular formation and the raphe nuclei of mdx and control mice. Cell numbers in the red nucleus were less than half those of control mice, while numbers in the other brainstem structures remained largely unchanged. Interestingly, the red nucleus is the only group of brainstem neurones studied that is directly involved in the control of voluntary movements.
Recently, investigation of the structural abnormalities in the CNS has been extended to the receptor level. Knuesel et al. (1999) found co-localization of the GABA A channel with dystrophin in the mouse cerebellum and hippocampus. In mdx mouse cerebellum and hippocampus there was a marked reduction of GABA A clusters, but not in the striatum, which does not normally contain dystrophin. This decrease in clustering was noted to be particularly striking around the soma of cerebellar Purkinje cells. In both the cerebellum and hippocampus, the number (but not size) of GABA A clusters was reduced by~50%. In the cerebral cortex, dystrophin clusters and GABA A clusters were observed separately, as well as groups of dystrophin and GABA A clusters together, indicating a possible GABA A -subset-dependent co-localization of dystrophin (Knuesel et al., 1999) .
Biochemical evidence for CNS involvement In DMD boys
The search for the biochemical mechanisms underlying the mental de®cit associated with lack of dystrophin has been necessarily limited. In 1994, Bresolin and colleagues published results from a PET study of¯uorodeoxyglucose uptake showing decreased uptake in the cerebellum in DMD boys (Bresolin et al., 1994) . This hypometabolism was shown not to occur in another subject of normal IQ with Wernig± Hoffman disease, suggesting that the cerebellar hypometabolism was unrelated to the motor de®cit. Glucose hypometabolism is a common feature of disorders with associated cognitive de®cits, and is generally indicative of lowered synaptic activity (Jueptner and Weiller, 1995) . The mechanisms that give rise to the hypometabolism can be varied and diverse.
In 1995 a paper showing altered bioenergetics in DMD was published (Tracey et al., 1995) . This study used neuropsychological testing and 31 P-magnetic resonance spectroscopy to examine the brains of 19 boys with DMD and 19 age-matched control boys. Results showed signi®cantly higher ratios of inorganic phosphate compared with ATP, phosphomonoesters (mainly phosphocholine and phosphoethanolamine) and phosphocreatine. There was no signi®cant correlation between these ratios and any measure of intellectual ability employed. Interestingly, the skeletal muscle of dystrophic boys has been shown to have a reduced total creatine and/or phosphocreatine concentration (Tarnopolsky and Parise, 1999) . Patients with neuromuscular disorders such as DMD have been shown to be chronically hypercapnic (Misuri et al., 2000) due to the pattern of rapid, shallow breathing and one might expect this to have an effect on brain energetics.
Boys with DMD have also been shown to have elevated levels of choline-containing compounds (glycero-and phosphocholine) in certain regions of their brains. An autopsy study showed increased (up to three times higher) cholinecontaining compounds in the frontal cortex in boys older than 17 years (Kato et al., 1997), while a study using magnetic resonance spectroscopy in vivo showed signi®cantly increased choline-containing compounds in the cerebellum, but not the cortex (Rae et al., 1998b) , of boys younger than 13 years. The ratio of choline-containing compounds to Nacetylaspartyl-containing compounds was shown to correlate signi®cantly with the boys' score on the Matrix Analogies Test, a measure of visuospatial cognitive ability that requires no verbal input and is tolerant of motor disability. As such, it is arguably a measure of DMD boys' underlying ability (i.e. taking verbal and motor de®cits into account). This suggested that the increase in choline-containing compounds was possibly a`compensatory' effect, although the authors pointed out that there was also a relationship between elevated choline-containing compounds and age, with the level of the compounds increasing with age. Cholinecontaining compounds are seen to be elevated in a number of brain disorders and are traditionally interpreted as symptomatic of increased membrane turnover or decreased membrane stability.
The cerebellar and hippocampal focus of the biochemical lesions in DMD are of interest due to the normally high expression of dystrophin in neurones found in these regions. Both Dorman et al. (1988) and Billard et al. (1998) noted that the reading de®cits seen in those with DMD are similar to those seen in phonological dyslexia (Castles and Coltheart, 1993) . Persons with phonological dyslexia, either developmental (Rae et al., 1998c; Nicolson et al., 1999) or acquired (Levisohn et al., 2000) , have been shown to have abnormalities in the right cerebellum. Similarly, de®cits in verbal working memory, a large component of the DMD cognitive de®cit (Hinton et al., 2000) are known to have a cerebellar focus (Desmond et al., 1997) .
In the mdx mouse
The accessibility of the mdx mouse model has meant that more invasive biochemical measurements have been possible. The bioenergetic abnormalities reported in DMD brain have also been documented in the mdx mouse, with an increased inorganic phosphate to phosphocreatine ratio and increased intracellular brain pH reported using 31 P-magnetic resonance spectroscopy in vivo (Tracey et al., 1996a) . The mice studied were aged in the range 180±240 days. These authors also reported a reduction in total creatine content in aged mdx mice compared with controls which was not found in younger (60±150 days) mice (Tracey et al., 1996b) . A similar reduction of creatine compounds is also re¯ected in muscle tissue of mdx mice (Pulido et al., 1998) .
Metabolism of glucose is altered in the brains of mice which lack dystrophin. A recent study , using intravenous injection of [1-13 C]glucose and subsequent isotopomer analysis using NMR (nuclear magnetic resonance) spectroscopy, has shown signi®cantly decreased free glucose in the brains of mdx mice compared with controls, but signi®cantly increased fractional enrichment and increased ux of 13 C into metabolites such as glutamate and GABA, suggesting a faster metabolic rate in the dystrophin-de®cient brain. Furthermore, muscimol, a GABA A (and partial GABA C ) agonist which normally induces sedation and decreases glucose use, has a decreased effect in mdx mice compared with controls. This suggests that the increased glucose use demonstrated in the mdx mouse brain may be due to decreased inhibitory input from the subset of abnormally clustered GABA A receptors.
Decreased bioenergetic buffering capacity would be expected to in¯uence susceptibility to hypoxia. Mehler and coworkers have shown that hippocampal pyramidal neurones from mdx mice demonstrate increased sensitivity to hypoxiainduced loss of synaptic transmission (Mehler et al., 1992) . A more recent study has shown more susceptibility of mdx hippocampal tissue slices to irreversible hypoxic failure compared with controls when kept in 10 mM glucose, but less susceptibility of mdx slices compared with controls when kept in 4 mM glucose (Godfraind et al., 2000) . A substratedependent difference in oxygen consumption rates has also been demonstrated in mdx brain cortical tissue slices (Rae et al., 1998a , which consume oxygen at signi®cantly higher rates than controls when metabolizing pyruvate at low oxygen partial pressures. In addition to decreased bioenergetic buffering capacity, the displayed altered response to hypoxia may also be in¯uenced by the reported reduced GABA A receptor clustering in dystrophin-de®cient mice (Knuesel et al., 1999) , as GABA A receptor activation has been shown to exacerbate oxygen-glucose deprivationinduced neuronal injury (Muir et al., 1996) .
A proton magnetic resonance study (Tracey et al., 1996b ) reported normal levels of N-acetylaspartate, a neuronal viability marker (Bates et al., 1996) , but increased wholebrain levels of choline-containing compounds (glycero-and phosphocholine) and myo-inositol. We have subsequently con®rmed the increase in choline-containing compounds and localized them to the cerebellum and hippocampus ).
An analysis of tissue from various organs in the mdx mouse, including the cerebellum, has shown that dystrophic tissue is easily distinguishable from control tissue based on its metabolic pro®le. Grif®n et al. (2001) identify discernible metabolic changes in glycolysis, b-oxidation, the TCA cycle, the phosphocreatine/ATP cycle, lipid metabolism and osmoregulation. These were all in the ®ve dystrophic tissues tested: cardiac muscle, diaphragm, skeletal muscle, cerebral cortex and cerebellum.
There is also some recent evidence suggesting that the water transporter aquaporin-4 is de®cient in the astrocytic end feet in mdx mice (Frigeri et al., 2001) . De®ciency of the water transporter has also been reported in the muscle (Frigeri et al., 2001) and erythrocyte membrane in DMD (Serbu et al., 1986) . The de®ciency in erythrocyte water transport is probably due to altered membrane¯uidity in the erythrocyte (Ferretti et al., 1990) , which does not normally express dystrophin. Altered expression of the dystrophin homologue b-spectrin has been reported, which is symptomatic of ®ndings of altered expression of a range of proteins homologous to dystrophin in DMD, with no consistent pattern emerging (Boivin, 1992) , although it has been suggested that it may result from genetic heterogeneity (Ashley and Goldstein, 1983) . Tracey et al. (1996a) reported increased extracellular and decreased intracellular volumes in mdx brain suggesting that the alteration in aquaporin-4 levels might result in alterations in the ability of cells in the brain to regulate cell volume. Although there has been one report of altered response to hypo-osmotic shock by mdx mouse muscle (Menke and Jockusch, 1991) , recent work ) has shown no difference in ef¯ux rates of [ 3 H]taurine from mdx cortical brain tissue slices compared with controls when exposed to hypo-osmotic shock. The increase in total brain myo-inositol in mdx mice (Tracey et al., 1996b) might be interpreted as a response to chronic osmotic stress, as myo-inositol has been shown to act as an organic osmolyte in the brain (Strange et al., 1993) .
Evidence from electrophysiological studies for an involvement of the CNS In DMD boys
There have been very few electrophysiological studies carried out on DMD patients, due in large part to the practical and ethical problems associated with undertaking these types of measurements on sick boys. Overall the studies indicate a functional neural de®cit in DMD. The majority of investigators, who have performed EEG studies on DMD patients, have found that a higher proportion (40±89%) of these patients display abnormalities compared with control groups or general age-matched population data (Wayne and Browne-Mayers, 1959; Perlstein et al., 1960; Zellweger and Niedermeyer, 1965; Nakao et al., 1968; Kozicka et al., 1971; Black, 1973; Florek and Karolak, 1977) . The most consistent abnormality found was 14 and 6/s positive spikes, an abnormality also present in vegetative seizures, behavioural episodes, atypical seizures, migraines, autonomic nervous system dysfunctions, syncope and paroxysmal abdominal pain (Poser and Ziegler, 1958; Perlstein et al., 1960; Zellweger and Niedermeyer, 1965; Nakao et al., 1968) . Unfortunately many of these studies lack appropriate control groups: Wayne and Browne-Mayers (1959) , Perlstein et al. (1960) , Zellweger and Niedermeyer (1965) , Kozicka et al. (1971) and Florek and Karolak (1977) did not perform EEG studies on their own control groups. Barwick et al. (1965) did use age-matched control boys and found abnormal or borderline recordings in 28% of DMD patients (n = 20) compared with 45% (n = 18) in the age-matched controls. Interestingly they did not observe any 14 and 6/s positive spikes. Zellweger and Niedermeyer (1965) suggest that this relatively low incidence of EEG abnormalities in DMD patients is due to small patient numbers and the criteria set for de®nition of positive spike activity. Nakao et al. (1968) found 60% of a DMD patient group (n = 80) had abnormal EEG recordings compared with 19% of a healthy school children control group (n = 16). They concluded that abnormal EEG recordings occur in a higher percentage of DMD patients than normal. Wayne and Browne-Mayers (1959) , Kozicka et al. (1971) , Black (1973) and Florek and Karolak (1977) do not indicate the precise nature of the EEG abnormalities they observed, which makes their ®ndings dif®cult to interpret.
It remains unclear if there is a correlation between IQ and EEG abnormalities in the DMD boys. Perlstein et al. (1960) did ®nd a correlation between these two factors, while Zellweger and Niedermeyer (1965) , Kozicka et al. (1971) , Black (1973) and Florek and Karolak (1977) found no correlation between EEG abnormalities and IQ. Nakao et al. (1968) mentions that patients with EEG abnormalities werè more often inferior' in intelligence to those with normal recordings. Perlstein et al. (1960) found a correlation between increasing age and increasing EEG abnormalities. In contrast Zellweger and Niedermeyer (1965) found no correlation between disease progression and EEG abnormalities. Similarly Wayne and Browne-Mayers (1959) and Nakao et al. (1968) found no correlation between severity of disease and EEG abnormalities.
More recently Di Lazzario et al. (1998) , using transcranial magnetic stimulation, reported that the excitability of the motor cortex is reduced in DMD patients (n = 4) compared with controls (n = 4). Central motor conduction time and excitability to electrical stimulation were unchanged in DMD patients, leading the authors to conclude that the reduction in motor cortex excitability in the DMD boys arose as a result of aberrant synaptic functioning, which is in agreement with biochemical evidence (Bresolin et al., 1994; Jueptner and Weiller, 1995) .
The mdx mouse has enabled rigorous electrophysiological investigation of functional abnormalities in the dystrophin de®cient CNS. Full-length dystrophin is absent in hippocampal cells in the mdx mouse (Lidov et al., 1996) and functional de®cits in these cells have been the subject of investigation in recent times. Both Mehler et al. (1992) and Godfraind et al. (2000) have demonstrated that CA1 hippocampal neurones display a signi®cantly increased susceptibility to hypoxiainduced reduction in synaptic transmission at Schaffer collateral/commissural CA1 synapses. Interestingly, there is no difference in long-term potentiation in CA1 and dentate gyrus cells in mdx mice (10±12 weeks) compared with controls (Sesay et al., 1996; Godfraind et al., 1997) .
Further studies have included another mouse model, the mdx 3cv , which lacks the Dp140 and Dp71 dystrophin isoforms, both of which are present in control and mdx brain tissue but lacking in many boys with Duchenne's. To this end, Vaillend et al. (1998) employed the brain slice technique to test synaptic plasticity in 21±24 week old mdx and mdx 3cv mice. In agreement with Sesay et al. (1996) , they found no de®ciency in synaptic transmission in either strain of mdx mice; however, post-tetanic potentiation was increased in mdx mice. Vaillend et al. (1999) went on to further characterize the difference in post-tetanic potentiation seen previously in the mdx mouse using brain slices from 3±5 month-old control and mdx mice. In contrast to their previous study, post-tetanic potentiation was not signi®cantly different in the mdx mouse compared with controls when the NMDA receptor antagonist D-APV (D-2-amino-5-phosphonovalerate) was present. Because of the indication that the NMDA receptor was affected by the lack of dystrophin, nNOS (nitric oxide synthase)-speci®c activity was also implicated due to NOS activation via NMDA-receptor mediated elevation of intracellular calcium levels. Accordingly they evoked pre-synaptic ®bre volleys and ®eld excitatory post-synaptic potentials mediated through both NMDA receptors and non-NMDA receptors. They found comparable synaptic responses in both NMDA and non-NMDA receptor subtypes of mdx and control mice. This indicates normal glutamatergic neuronal transmission, and hence preserved nNOS activity. The authors argue that the differences seen in short-term potentiation are due to a postsynaptic rather than a pre-synaptic mechanism. Using voltage-gated calcium channel antagonists nifedipine and NiCl 2 they found no difference in potentiation in either mdx or control mice, indicating that these channels are not responsible for their observations.
Conclusion and clinical implications
In recent years there has been a substantial increase in our understanding of the role of dystrophin in the CNS. These studies have been largely carried out on DMD boys and the dystrophin de®cient mdx mouse and have demonstrated a range of abnormalities in CNS function, from behavioural and cognitive dysfunction to alterations in the clustering of ion channels in single identi®ed neurones.
The major clinical issue in DMD is the skeletal muscle pathology, and this has understandably received the greatest attention. There has been very little clinical investigation of the role of dystrophin in the CNS in DMD. However, with the dramatic increase in our understanding of this role over the last decade or so, as detailed in this review, there is now a suf®cient body of data on the functions of dystrophin in the CNS, and the implications of its disruption, for its clinical relevance to begin to be appreciated. This potential clinical relevance may best be illustrated by consideration of the potential impact of a disruption in the distribution and function of the inhibitory receptor GABA A . A disruption of GABA A receptors may impact clinically in at least three areas: clinical ef®cacy of drugs, sleep disorders and motor control.
Many substances widely used in clinical medicine exert their in¯uence exclusively or in part by binding to the GABA A receptor. It is now reasonably well established that substances such as barbiturates, benzodiazepines, anaesthetics and corticosteroids interact with the GABA A receptor in the CNS (for a review, see Johnston, 1996) . If boys with DMD have an abnormality in distribution and function of these receptors then the ef®cacy of these substances could be altered. GABA disruption may also in part explain the sleep disorders suffered by many DMD boys. Sleep disorders in DMD are characterized by sleep fragmentation, increased arousal frequency and REM (rapid eye movement) sleep deprivation (Redding et al., 1985) . Interestingly, a recent review on the role of GABA receptors in sleep regulation provides evidence suggesting that activation of GABA A receptors is crucial in both the initiation and maintenance of non-REM sleep and in the generation of sleep spindles (Lancel, 1999) . Finally, the motor problems experienced by boys with DMD are, of course, due largely to the skeletal muscle pathology. A disruption of normal motor control function may also have an impact on the ability of DMD boys to learn and carry out movement, and to compensate for the structural deformities in skeletal muscle. The cerebellum is a part of the motor control system, and has been shown to play a major role in such aspects of motor behaviour as motor task automation, motor learning and timing functions associated with motor tasks (Ivry and Keel, 1985; Jenkins et al., 1994) . As detailed above, the cerebellar Purkinje cells in the mdx mouse have a disruption in GABA A cluster size and, if a similar disruption occurs in DMD boys resulting in some abnormality in cerebellar function, it could in¯uence their ability to learn and execute motor tasks. Although these three examples of possible clinical relevance of GABA A receptor abnormalities are speculative, they indicate the potential importance of an understanding of the role of dystrophin in the CNS to the clinical management of boys with DMD.
